1 Marrow relapse is the major obstacle to
cure for 10-15% of young patients with acute lymphoblast
2 At 120 degrees C, the strength of composite
cured for 10 min was 178 +/- 17, lower than 236 +/- 14 o
3 cobacteria in vitro than patients who remain
cured for 2 years.
4 8 +/- 17, lower than 236 +/- 14 of composite
cured for 3 hrs.
5 The proportion
cured for 3-mo regimens containing rifampicin or rifapen
6 we describe in one affected dog a functional
cure for a severe erythroid disease using stem cell sele
7 rrow transplantation (BMT) is the only known
cure for a variety of inherited diseases and requires th
8 nticipate long-term survival, and possibly a
cure, for a significant fraction of CNS lymphoma patient
9 n trials remains a major hurdle in advancing
cures for a number of otherwise incurable diseases.
10 There is currently no
cure for AD and no reliable method of diagnosis other th
11 s the deadliest form of skin cancer, with no
cure for advanced disease.
12 ntially offer amelioration--and perhaps even
cure--for afflicted individuals.
13 ells that constitutes the major barrier to a
cure for AIDS is exquisitely redox sensitive and could b
14 istence is therefore the major obstacle to a
cure for AIDS.
15 are targeted to lead to viral eradication--a
cure for AIDS.
16 uld be induced in humans, it could provide a
cure for AIDS.
17 l potential of rAAV-CFTRDeltaR in offering a
cure for all patients with CF in the future.
18 Currently there is no
cure for AMD, but several treatment options have started
19 Currently, there is no
cure for asthma, only symptomatic treatment.
20 Unfortunately, there is no
cure for asthma.
21 Because there is no
cure for autoimmunity, it is extremely important to stud
22 otion of crude shark cartilage extracts as a
cure for cancer has contributed to at least two signific
23 relapse are major obstacles in identifying a
cure for cancer.
24 ver the last few decades in the search for a
cure for cancer.
25 ity and remains a hurdle in the search for a
cure for cancer.
26 on the continuing struggle to find effective
cures for cancer.
27 Finding a
cure for cardiovascular disease remains a major unmet me
28 e good outcomes overall, the likelihood of a
cure for certain sites and histologic conditions is less
29 A
cure for CHC was associated with an MRR of 0.64 (95% CI,
30 prognostic for outcome, but did not prevent
cure for children with acute lymphoblastic leukemia (ALL
31 e to oral chemotherapy regimens in attaining
cure for children with acute lymphoblastic leukemia (ALL
32 A "
cure" for chronic hepatitis C remains elusive.
33 inues to serve as a platform of "operational
cure" for CML with TKIs and immunotherapies.
34 but has fallen short of delivering effective
cures for complex human diseases with complicated causes
35 e project has sparked hope and optimism that
cures for debilitating conditions can be achieved and ta
36 Light cure is a popular mode of
curing for dental adhesives.
37 ide reasons for optimism in the search for a
cure for devastating autoimmune diseases.
38 Two promising approaches toward a cell-based
cure for diabetes are the directed differentiation of pl
39 islet transplantation has raised hopes for a
cure for diabetes mellitus, especially in patients with
40 Here, we describe a potential
cure for diabetes using a cellular therapy to ameliorate
41 xpansion of autoreactive T cells; however, a
cure for diabetes would require tolerance to be establis
42 -producing cells in vitro could constitute a
cure for diabetes, recent studies have explored the mole
43 With the ultimate hope of finding a
cure for diabetes, researches are looking into altering
44 Islet transplantation is a promising
cure for diabetes.
45 The composites were light-
cured for different time periods (9 s, 12 s, 25 s, 40 s,
46 caffolds in tissue engineering or developing
cures for diseases associated with protein fibers.
47 To find
cures for diseases like breast cancer that rely on epith
48 optimal primary preventions, treatments and
cures for diseases.
49 velopment of safe, permanent, and functional
cures for diverse genetic and nongenetic diseases.
50 There is currently no
cure for DMD although various promising approaches are p
51 There is no
cure for DMD and current therapeutic approaches to resto
52 onset of pathology might convey a long-term
cure for DMD.
53 The search for a
cure for Duchenne muscular dystrophy and other muscular
54 A
cure for dystrophin-deficient muscular dystrophy require
55 etween NV1023 and NV1042, with five of seven
cures for each virus.
56 herapy is associated with the best chance of
cure for EGCTs.
57 Transplantation is a
cure for end-stage organ failure but, in the absence of
58 Transplantation is the only
cure for end-stage organ failure, but without immunosupp
59 urrently, there is no effective treatment or
cure for epidermolysis bullosa, but bone marrow transpla
60 roject of the Epilepsy Foundation, Finding A
Cure for Epilepsy and Seizures.
61 's diversity currently thwarts our goal of a
cure for every patient, but recent integration of genomi
62 The only proven
cure for Fanconi anemia (FA)-associated bone marrow fail
63 Until a
cure for FMS is found, CAM providers may offer an econom
64 However, a
cure for food allergy has not yet been achieved and pati
65 ptoms of disease, but currently, there is no
cure for food allergy.
66 There is currently no
cure for fragile X, although medications targeting speci
67 While there is no definitive
cure for FXS, the understanding of FMRP function has pav
68 and the murine model (Twitcher), there is no
cure for GLD.
69 n (HDF), dedicated to finding treatments and
cures for HD.
70 Gene therapy may provide a
cure for hemophilia and overcome the limitations of prot
71 eption of liver transplantation, there is no
cure for hemophilia, which is currently managed by preem
72 Current efforts toward achieving a
cure for HIV are focused on developing strategies to eli
73 research towards achievment of a functional
cure for HIV in neonates, including difficult trade-offs
74 The search for a
cure for HIV infection has highlighted the need for incr
75 Achievement of a
cure for HIV infection might need reactivation of latent
76 search has been energized by prospects for a
cure for HIV infection or, at least, for a "functional c
77 search efforts are now underway to develop a
cure for HIV infection, allowing patients to discontinue
78 Second, scientists are trying to develop a
cure for HIV infection, which would alleviate the need f
79 V, there is intense interest in developing a
cure for HIV infection.
80 ding HIV latency that might lead to a future
cure for HIV infection.
81 oved viral control and possibly a functional
cure for HIV infection.
82 ABTRACT: Establishing a
cure for HIV is hindered by the persistence of latently
83 A
cure for HIV is still greatly needed and has become a gl
84 The quest for a
cure for HIV remains a timely and key challenge for the
85 een captured by the possibility of finding a
cure for HIV transmitted from mother to child.
86 will not lead to a functional or sterilizing
cure for HIV(+) patients.
87 istic picture of what a generally applicable
cure for HIV-1 infection is likely to entail.
88 dividual, have renewed interest in finding a
cure for HIV-1 infection.
89 ent a major obstacle to finding a functional
cure for HIV-1 infection.
90 mulation as a strategy aimed at a functional
cure for HIV-1 infection.
91 viral therapy (ART) is critical to finding a
cure for HIV-1.
92 f the immune system may eventually lead to a
cure for HIV-infected patients.
93 Such intervention might possibly lead to a
cure for HIV-infected patients.
94 ategies to eradicate or develop a functional
cure for HIV.
95 id in the development of strategies toward a
cure for HIV.
96 Given the difficulty in finding a
cure for HIV/AIDS, a promising prevention strategy to re
97 development of novel therapies and potential
cures for HIV infection.
98 ven the renewed effort to identify potential
cures for HIV.
99 As there is no
cure for HLB, insect vector management is considered one
100 The clinical cure rate at test-of-
cure for hospital-acquired cIAI was higher with moxiflox
101 A major challenge in the development of a
cure for human immunodeficiency virus (HIV) has been the
102 Research toward a
cure for human immunodeficiency virus type 1 (HIV-1) inf
103 vast potential of the oceans to lead to new
cures for human and animal disease; the exploitation of
104 Although there is no
cure for idiopathic pulmonary arterial hypertension, rec
105 To estimate chance of
cure for individual patients, a nomogram was developed,
106 biology holds future promise for developing
cures for infectious diseases, cancer, and autoimmune di
107 ent there is no disease modifying therapy or
cure for it; and management of the disease is limited to
108 m remains unclear, and there is currently no
cure for KS.
109 There is no
cure for LEMS, and the current most commonly used sympto
110 lete surgical resection offers the chance of
cure for localized gastric cancer.
111 Identifying
cures for long-term problems of a complex developmental
112 elopment of new diagnostics, treatments, and
cure for many diseases.
113 The major impediment to
cure for many malignancies is the development of therapy
114 ere are currently no effective treatments or
cures for MDC1A.
115 ts to treat MDS; however, the only potential
cure for MDS remains stem cell transplantation.
116 e fatalities; however, there is no effective
cure for men with advanced disease and additional therap
117 ic stem cell (HSC) transplantation, the only
cure for most hematopoietic diseases.
118 common inherited anemias, with no effective
cure for most patients.
119 onstrate the ability to produce a phenotypic
cure for murine SCD using a nonmyeloablative protocol wi
120 Progress toward finding a
cure for muscle diseases has been slow because of the ab
121 d gene therapy research raise the hope for a
cure for muscular dystrophy in the near future.
122 he only therapeutic modality that provides a
cure for myelofibrosis patients.
123 There are no
cures for neurodegenerative diseases and this is partial
124 ne marrow transplantation (BMT) represents a
cure for nonmalignant hematological disorders.
125 There is no
cure for or licensed vaccine against CHIKV infection.
126 METHODS AND FINDINGS: The
cures for osteoporosis are limited, consequently the pot
127 There is no
cure for PAH, despite effective treatments, and outcomes
128 l resection provides the only possibility of
cure for pancreas cancer.
129 rd improved quality of life and eventually a
cure for patients suffering from EB, a currently intract
130 ne therapy may present a treatment but not a
cure for patients who have already experienced vision lo
131 rucial intervention and provides a chance of
cure for patients with cancer.
132 etic cell transplantation may offer the only
cure for patients with hematological diseases.
133 that target causes and ultimately provide a
cure for patients with irritable bowel syndrome.
134 Although surgery offers the best chance of
cure for patients with non-small cell lung cancer (NSCLC
135 In addition to providing a potential
cure for patients with pyruvate kinase deficiency, in vi
136 There is no
cure for patients with stage IV NSCLC.
137 emporary to chronic control of disease, or a
cure, for patients with advanced-stage solid cancers.
138 gation aimed at exploring the prospects of a
cure for persistent medullary thyroid cancer (MTC) strat
139 om bone marrow transplantation, a definitive
cure for Philadelphia (Ph) chromosome-positive chronic m
140 Bone marrow transplantation remains the only
cure for PNH but should be reserved for patients with su
141 Currently, delivery is the only
cure for preeclampsia; therefore, effective prevention a
142 that rescues TorsinADeltaE could serve as a
cure for primary dystonia.
143 A
cure for prostate cancer (CaP) will be possible only aft
144 Currently no
cure for psoriasis is available due to limited knowledge
145 There are no causal
cures for psychiatric disorders and available therapies
146 FMT is a highly effective
cure for RCDI, but increased knowledge of the intestinal
147 Until recently, the only
cure for relapse after allogeneic bone marrow transplant
148 Gene transfer therapy is the most promising
cure for retinal dystrophies and has primarily been appl
149 Current approaches offer no
cures for rheumatoid arthritis (RA).
150 s one of the primary targets in developing a
cure for SCI.
151 At present, there are no "
cures" for secondary metastatic cancer of any form and t
152 Cerebral hemispherectomy remains the only
cure for seizures, but there are inevitable functional c
153 Our report suggests some hope of
cure for selected patients with severe forms of this dis
154 ion with reduced-intensity conditioning is a
cure for several nonmalignant hematologic disorders that
155 etic stem cell transplant (HSCT) is the only
cure for sickle cell disease (SCD).
156 Currently, there is no
cure for Sjogren's syndrome, and treatment is mainly pal
157 Since there is no effective
cure for SMA presently, prevention through the identific
158 le drugs is variable; a drug that provides a
cure for some may confer no therapeutic benefit or trigg
159 ars from discontinuation provides hope for a
cure for some patients.
160 th acute myeloid leukemia (AML) and provided
cure for some.
161 ightforward and simple solution to provide a
cure for T1D is immensely attractive but entails at leas
162 ans for truly identifying the cause of and a
cure for T1D.
163 ver, there is still no universally available
cure for thalassemias.
164 critical first step toward development of a
cure for the 400 million patients who are chronically in
165 There is no
cure for the advanced disease.
166 nes into autologous stem cells and provide a
cure for the BM failure in FA patients.
167 nes into autologous stem cells and provide a
cure for the BM failure in FA patients.
168 The rates of hospital mortality and clinical
cure for the continuous versus intermittent infusion gro
169 Liver transplantation offers the only
cure for the genetic defect causing FAP and appears to r
170 rrow transplantation (BMT) is the only known
cure for the hematologic manifestations of Fanconi anemi
171 at current standard therapy does not lead to
cure for the majority of patients with B-cell malignanci
172 eatment durations may be possible to achieve
cure for the majority of patients with M/XDR-TB.
173 iptionally dormant cells currently thwarts a
cure for the more than 35 million individuals infected w
174 d bone marrow transplantation as a potential
cure for the syndrome, which is usually lethal within th
175 e of type 1 diabetes (T1D) and developing a "
cure" for the disease.
176 f biologic systems and on the development of
cures for the latter.
177 al connections needed for the development of
cures for the most common and devastating diseases invol
178 is of these cancers but also the hope of the
cure for these cancers.
179 experience, looking ahead to the chance of a
cure for these disorders.
180 ly, gene therapy may be possible, leading to
cures for these sight-threatening diseases.
181 or a complete understanding of, and eventual
cure for,
these childhood epilepsy syndromes.
182 nerstones of the successful development of a
cure for this chronic disease.
183 A permanent
cure for this condition can be achieved by closing the p
184 There has been no
cure for this condition, but replacement of deficient he
185 earch for a genuinely effective treatment or
cure for this dementia.
186 ire an intense research focus as we pursue a
cure for this devastating disease.
187 model opens new opportunities for finding a
cure for this devastating neurodegenerative disease.
188 ursors suggest that cell therapy may offer a
cure for this devastating neurological disease.
189 There is no
cure for this disease and current treatment modalities f
190 Still there is no
cure for this disease and more promising treatments are
191 cell transplantation (SCT) is the only known
cure for this disease.
192 S there is still no effective vaccine and no
cure for this disease.
193 er, to apoptosis is the key for developing a
cure for this disease.
194 of worm genetics to bear on the search for a
cure for this disease; work on this worm has already led
195 There is no complete
cure for this heterogeneous group of diseases, but a sen
196 ce to this agent mitigates the prospect of a
cure for this leukemia.
197 As yet, there is no
cure for this neuromuscular disorder which affects the l
198 tive catheter ablation will be as a longterm
cure for this type of VT.
199 There is no
cure for this, partly because cavities and scar tissue f
200 t, and as yet unsolved, challenge to develop
cures for this disease.
201 There is no
cure for tics, and symptomatic therapy includes behavior
202 ic iliac lymphadenectomy, with the intent to
cure, for transitional-cell carcinoma of the bladder bet
203 h as radiofrequency ablation offer potential
cure for tumors detected at an early stage in well selec
204 dio frequency ablation offer the chance of a
cure for tumors detected at an early stage in well selec
205 A logical
cure for type 1 diabetes (T1D) involves replacing the lo
206 let transplantation is a promising potential
cure for type 1 diabetes (T1D).
207 There is yet no
cure for type 1 diabetes (T1DM) so far.
208 l in facilitating islet transplantation as a
cure for type 1 diabetes mellitus.
209 A
cure for type 1 diabetes will probably require the provi
210 Islet transplantation represents a potential
cure for type 1 diabetes, yet persistent autoimmune and
211 orldwide epidemic of type 2 diabetes and the
cure for type 1 diabetes.
212 Although there is no known
cure for Type 2 diabetes, early diagnosis and interventi
213 Islet transplantation provides a "
cure" for type 1 diabetes but is limited in part by recu